Загрузка...
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)
The NAD-hydrolyzing ecto-enzyme CD38 is overexpressed by multiple myeloma and other hematological malignancies. We recently generated CD38-specific nanobodies, single immunoglobulin variable domains derived from heavy-chain antibodies naturally occurring in llamas. Nanobodies exhibit high solubility...
Сохранить в:
| Опубликовано в: : | Cells |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072387/ https://ncbi.nlm.nih.gov/pubmed/32013131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9020321 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|